Dr. Hillard Lazarus, MD

Hematology & Oncology Cleveland, OH Male
NPI: 1255351920
Total Payments
$2.5M
2024 Payments
$316,277
Companies
21
Transactions
1,207

Payment Breakdown by Category

Consulting$1.4M (56.9%)
Other$907,104 (36.0%)
Travel$157,290 (6.2%)
Food & Beverage$21,288 (0.8%)
Education$99.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $1.4M 100 56.9%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $860,044 269 34.1%
Travel and Lodging $157,290 475 6.2%
Honoraria $47,060 15 1.9%
Food and Beverage $21,288 347 0.8%
Education $99.00 1 0.0%

Top Paying Companies

Company Total Records Latest Year
Partner Therapeutics, Inc. $1.3M 78 $0 (2024)
JAZZ PHARMACEUTICALS INC. $309,123 284 $0 (2024)
Seattle Genetics, Inc. $193,566 235 $0 (2019)
E.R. Squibb & Sons, L.L.C. $188,002 167 $0 (2019)
Seagen Inc. $137,097 114 $0 (2023)
Celgene Corporation $78,248 39 $0 (2022)
AstraZeneca Pharmaceuticals LP $68,316 72 $0 (2022)
Pharmacyclics LLC, An AbbVie Company $45,512 65 $0 (2019)
Amgen Inc. $35,608 43 $0 (2024)
CSL Behring $33,050 24 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $316,277 78 Partner Therapeutics, Inc. ($261,457)
2023 $363,016 66 Partner Therapeutics, Inc. ($289,179)
2022 $375,338 90 Partner Therapeutics, Inc. ($276,533)
2021 $366,498 42 Partner Therapeutics, Inc. ($321,980)
2020 $281,060 85 Partner Therapeutics, Inc. ($192,721)
2019 $234,165 253 E.R. Squibb & Sons, L.L.C. ($61,747)
2018 $341,450 360 Seattle Genetics, Inc. ($103,397)
2017 $243,042 233 Jazz Pharmaceuticals Inc. ($85,896)

All Payment Transactions

1,207 individual payment records from CMS Open Payments — Page 1 of 49

Date Company Product Nature Form Amount Type
12/12/2024 Partner Therapeutics, Inc. LEUKINE (Drug) Consulting Fee Cash or cash equivalent $15,000.00 General
Category: Hematology/Oncology
12/04/2024 JAZZ PHARMACEUTICALS INC. DEFITELIO (Drug) Travel and Lodging In-kind items and services $400.14 General
Category: HEMATOLOGY/ONCOLOGY
12/04/2024 JAZZ PHARMACEUTICALS INC. DEFITELIO (Drug) Travel and Lodging In-kind items and services $167.50 General
Category: HEMATOLOGY/ONCOLOGY
12/04/2024 JAZZ PHARMACEUTICALS INC. DEFITELIO (Drug) Travel and Lodging In-kind items and services $42.00 General
Category: HEMATOLOGY/ONCOLOGY
12/04/2024 JAZZ PHARMACEUTICALS INC. DEFITELIO (Drug) Travel and Lodging In-kind items and services $30.97 General
Category: HEMATOLOGY/ONCOLOGY
12/04/2024 JAZZ PHARMACEUTICALS INC. DEFITELIO (Drug) Food and Beverage In-kind items and services $24.87 General
Category: HEMATOLOGY/ONCOLOGY
12/04/2024 JAZZ PHARMACEUTICALS INC. DEFITELIO (Drug) Travel and Lodging In-kind items and services $11.25 General
Category: HEMATOLOGY/ONCOLOGY
11/26/2024 Partner Therapeutics, Inc. LEUKINE (Drug) Consulting Fee Cash or cash equivalent $15,000.00 General
Category: Hematology/Oncology
11/07/2024 JAZZ PHARMACEUTICALS INC. DEFITELIO (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $5,460.00 General
Category: HEMATOLOGY/ONCOLOGY
11/03/2024 Amgen Inc. Blincyto (Biological) Travel and Lodging Cash or cash equivalent $98.21 General
Category: Oncology
11/03/2024 Amgen Inc. Blincyto (Biological) Food and Beverage Cash or cash equivalent $48.59 General
Category: Oncology
11/03/2024 Amgen Inc. Blincyto (Biological) Travel and Lodging Cash or cash equivalent $40.20 General
Category: Oncology
11/03/2024 Amgen Inc. Blincyto (Biological) Travel and Lodging Cash or cash equivalent $23.40 General
Category: Oncology
10/31/2024 Amgen Inc. Blincyto (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,600.00 General
Category: Oncology
10/31/2024 Amgen Inc. Blincyto (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,200.00 General
Category: Oncology
10/31/2024 JAZZ PHARMACEUTICALS INC. DEFITELIO (Drug) Food and Beverage In-kind items and services $122.11 General
Category: HEMATOLOGY/ONCOLOGY
10/28/2024 Amgen Inc. Blincyto (Biological) Travel and Lodging Cash or cash equivalent $54.98 General
Category: Oncology
10/28/2024 Amgen Inc. Blincyto (Biological) Travel and Lodging Cash or cash equivalent $40.20 General
Category: Oncology
10/28/2024 Amgen Inc. Blincyto (Biological) Food and Beverage Cash or cash equivalent $15.36 General
Category: Oncology
10/28/2024 Amgen Inc. Blincyto (Biological) Travel and Lodging Cash or cash equivalent $11.70 General
Category: Oncology
10/27/2024 Amgen Inc. Blincyto (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,600.00 General
Category: Oncology
10/27/2024 Amgen Inc. Blincyto (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,200.00 General
Category: Oncology
10/23/2024 Amgen Inc. Blincyto (Biological) Travel and Lodging In-kind items and services $213.12 General
Category: Oncology
10/22/2024 Amgen Inc. Blincyto (Biological) Food and Beverage In-kind items and services $116.07 General
Category: Oncology
10/16/2024 Partner Therapeutics, Inc. LEUKINE (Drug) Consulting Fee Cash or cash equivalent $15,000.00 General
Category: Hematology/Oncology
123…49»

About Dr. Hillard Lazarus, MD

Dr. Hillard Lazarus, MD is a Hematology & Oncology healthcare provider based in Cleveland, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1255351920.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hillard Lazarus, MD has received a total of $2.5M in payments from pharmaceutical and medical device companies, with $316,277 received in 2024. These payments were reported across 1,207 transactions from 21 companies. The most common payment nature is "Consulting Fee" ($1.4M).

Practice Information

  • Specialty Hematology & Oncology
  • Location Cleveland, OH
  • Active Since 07/19/2006
  • Last Updated 06/29/2011
  • Taxonomy Code 207RH0003X
  • Entity Type Individual
  • NPI Number 1255351920

Products in Payments

  • LEUKINE (Drug) $752,075
  • Leukine (Drug) $589,796
  • ADCETRIS (Biological) $303,919
  • EMPLICITI (Biological) $165,984
  • VYXEOS (Drug) $162,742
  • Defitelio (Drug) $93,450
  • CALQUENCE (Drug) $68,316
  • DEFITELIO (Drug) $52,931
  • Imbruvica (Drug) $45,512
  • Blincyto (Biological) $32,864
  • SGN35 (Biological) $32,724
  • Hizentra (Biological) $25,082
  • OPDIVO (Biological) $22,017
  • TASIGNA (Drug) $20,380
  • Revlimid (Drug) $20,101
  • IMBRUVICA (Drug) $15,103
  • NINLARO (Drug) $11,406
  • ABECMA (Biological) $9,450
  • Privigen (Biological) $3,749
  • Yescarta (Drug) $252.28

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Hematology & Oncology Doctors in Cleveland

Jorge Garcia, Md, MD

Hematology & Oncology — Payments: $765,093

Hematology & Oncology $765,093

Ronald Bukowski, Md, MD

Hematology & Oncology — Payments: $744,876

Hematology & Oncology $744,876

Balazs Halmos, Md, MD

Hematology & Oncology — Payments: $548,525

Hematology & Oncology $548,525

Dr. Dale Shepard, M.d., Ph.d, M.D., PH.D

Hematology & Oncology — Payments: $481,414

Hematology & Oncology $481,414

Bachar Dergham, Md, MD

Hematology & Oncology — Payments: $456,653

Hematology & Oncology $456,653

Dr. Brian Hill, M.d., Ph.d, M.D., PH.D

Hematology & Oncology — Payments: $334,203

Hematology & Oncology $334,203